Company: HVIIR
Filing Date: 2025-12-23
Form Type: S-4
Source: 0001493152-25-029121
Chunk: 148

Company: Hennessy Capital Investment Corp. VII
Filing Date: 2025-12-23
Form: S-4
Chunk 148
---
, the terms may not be fair from a financial point of view to the HVII Public Shareholders.

In analyzing the Business Combination, the HVII Board conducted significant due diligence on ONE Nuclear. For a complete discussion of the factors utilized by the HVII Board in approving the Business Combination, see the section of this proxy statement/prospectus entitled, “ The Business Combination — HVII’s Board of Directors’ Reasons for the Approval of the Business Combination.” The HVII Board believes because of the financial skills and background of its directors, it was qualified to conclude that the Business Combination was fair from a financial perspective to HVII Public Shareholders and that HVII’s fair market value was at least 80% of HVII’s net assets (excluding any taxes payable on interest earned). Notwithstanding the foregoing, the HVII Board did not obtain a fairness opinion to assist it in its determination. Accordingly, the HVII Board may be incorrect in its assessment of the Business Combination.

| 91 |

If, following the Business Combination, securities or industry analysts do not publish or cease publishing research or reports about New ONE Nuclear, its business, or its market, or if they change their recommendations regarding New ONE Nuclear’s securities adversely, the price and trading volume of New ONE Nuclear’s securities could decline.

The trading market for New ONE Nuclear Securities will be influenced by the research and reports that industry or securities analysts may publish about New ONE Nuclear, its business, market or competitors. Securities and industry analysts do not currently, and may never, publish research on New ONE Nuclear. If no securities or industry analysts commence coverage of New ONE Nuclear, New ONE Nuclear’s share price and trading volume would likely be negatively impacted. If any of the analysts who may cover New ONE Nuclear change their recommendation regarding New ONE Nuclear Common Stock adversely, or provide more favorable relative recommendations about New ONE Nuclear’s competitors, the price of New ONE Nuclear Common Stock would likely decline. If any analyst who may cover New ONE Nuclear were to cease coverage of New ONE Nuclear or fail to regularly publish reports on it, New ONE Nuclear could lose visibility in the financial markets, which in turn could cause its share price or trading volume to decline.

Past performance by HVII’s management team, HVII’s advisors and their respective affiliates, including investments and transactions in which they have participated and businesses with which they have been associated, may not be indicative of future performance of an investment in New ONE Nuclear.

Information regarding HVII’s management team, HVII’s advisors and their respective affiliates, including investments and transactions